Cargando…

Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary

BACKGROUND: Common cancerous histological types associated with endometriosis are clear cell carcinoma (CCC) and endometrioid carcinoma (EC). CCC is regarded as an aggressive, chemoresistant histological subtype. Magnetic resonance imaging (MRI) offers some potential advantages to diagnose ovarian t...

Descripción completa

Detalles Bibliográficos
Autores principales: Morioka, Sachiko, Kawaguchi, Ryuji, Yamada, Yuki, Iwai, Kana, Yoshimoto, Chiharu, Kobayashi, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388492/
https://www.ncbi.nlm.nih.gov/pubmed/30803452
http://dx.doi.org/10.1186/s13048-019-0497-1
_version_ 1783397775253176320
author Morioka, Sachiko
Kawaguchi, Ryuji
Yamada, Yuki
Iwai, Kana
Yoshimoto, Chiharu
Kobayashi, Hiroshi
author_facet Morioka, Sachiko
Kawaguchi, Ryuji
Yamada, Yuki
Iwai, Kana
Yoshimoto, Chiharu
Kobayashi, Hiroshi
author_sort Morioka, Sachiko
collection PubMed
description BACKGROUND: Common cancerous histological types associated with endometriosis are clear cell carcinoma (CCC) and endometrioid carcinoma (EC). CCC is regarded as an aggressive, chemoresistant histological subtype. Magnetic resonance imaging (MRI) offers some potential advantages to diagnose ovarian tumors compared with ultrasonography or computed tomography. This study aimed to identify MRI features that can be used to differentiate between CCC and EC. METHODS: We searched medical records of patients with ovarian cancers who underwent surgical treatment at Nara Medical University Hospital between January 2008 and September 2018; we identified 98 patients with CCC or EC who had undergone preoperative MRI. Contrasted MRI scans were performed less than 2 months before surgery. Patients were excluded from the study if they had no pathology, other pathological subtype of epithelial ovarian cancer, and/or salvage treatment for recurrence and metastatic ovarian cancer at the time of study initiation. Clinically relevant variables that were statistically significant by univariate analysis were selected for subsequent multivariate regression analysis to identify independent factors to distinguish CCC from EC. RESULTS: MRI of CCC and EC showed a large cystic heterogeneous mixed mass with mural nodules protruding into the cystic space. Univariate logistic regression analysis revealed that the growth pattern (broad-based nodular structures [multifocal/concentric sign] or polypoid structures [focal/eccentric sign]), surface irregularity (a smooth/regular surface or a rough/irregular/lobulated surface), “Width” of mural nodule, “Height-to-Width” ratio (HWR), and presence of preoperative ascites were factors that significantly differed between CCC and EC. In the multivariate logistic regression analysis, the growth pattern of the mural nodule (odds ratio [OR] = 0.69, 95% confidence interval [CI]: 0.013–0.273, p = 0.0004) and the HWR (OR = 3.71, 95% CI: 1.128–13.438, p = 0.036) were independent predictors to distinguish CCC from EC. CONCLUSIONS: In conclusion, MRI data showed that the growth pattern of mural nodules and the HWR were independent factors that could allow differentiation between CCC and EC. This finding may be helpful to predict patient prognosis before operation.
format Online
Article
Text
id pubmed-6388492
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63884922019-03-19 Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary Morioka, Sachiko Kawaguchi, Ryuji Yamada, Yuki Iwai, Kana Yoshimoto, Chiharu Kobayashi, Hiroshi J Ovarian Res Research BACKGROUND: Common cancerous histological types associated with endometriosis are clear cell carcinoma (CCC) and endometrioid carcinoma (EC). CCC is regarded as an aggressive, chemoresistant histological subtype. Magnetic resonance imaging (MRI) offers some potential advantages to diagnose ovarian tumors compared with ultrasonography or computed tomography. This study aimed to identify MRI features that can be used to differentiate between CCC and EC. METHODS: We searched medical records of patients with ovarian cancers who underwent surgical treatment at Nara Medical University Hospital between January 2008 and September 2018; we identified 98 patients with CCC or EC who had undergone preoperative MRI. Contrasted MRI scans were performed less than 2 months before surgery. Patients were excluded from the study if they had no pathology, other pathological subtype of epithelial ovarian cancer, and/or salvage treatment for recurrence and metastatic ovarian cancer at the time of study initiation. Clinically relevant variables that were statistically significant by univariate analysis were selected for subsequent multivariate regression analysis to identify independent factors to distinguish CCC from EC. RESULTS: MRI of CCC and EC showed a large cystic heterogeneous mixed mass with mural nodules protruding into the cystic space. Univariate logistic regression analysis revealed that the growth pattern (broad-based nodular structures [multifocal/concentric sign] or polypoid structures [focal/eccentric sign]), surface irregularity (a smooth/regular surface or a rough/irregular/lobulated surface), “Width” of mural nodule, “Height-to-Width” ratio (HWR), and presence of preoperative ascites were factors that significantly differed between CCC and EC. In the multivariate logistic regression analysis, the growth pattern of the mural nodule (odds ratio [OR] = 0.69, 95% confidence interval [CI]: 0.013–0.273, p = 0.0004) and the HWR (OR = 3.71, 95% CI: 1.128–13.438, p = 0.036) were independent predictors to distinguish CCC from EC. CONCLUSIONS: In conclusion, MRI data showed that the growth pattern of mural nodules and the HWR were independent factors that could allow differentiation between CCC and EC. This finding may be helpful to predict patient prognosis before operation. BioMed Central 2019-02-25 /pmc/articles/PMC6388492/ /pubmed/30803452 http://dx.doi.org/10.1186/s13048-019-0497-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Morioka, Sachiko
Kawaguchi, Ryuji
Yamada, Yuki
Iwai, Kana
Yoshimoto, Chiharu
Kobayashi, Hiroshi
Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary
title Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary
title_full Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary
title_fullStr Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary
title_full_unstemmed Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary
title_short Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary
title_sort magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388492/
https://www.ncbi.nlm.nih.gov/pubmed/30803452
http://dx.doi.org/10.1186/s13048-019-0497-1
work_keys_str_mv AT moriokasachiko magneticresonanceimagingfindingsfordiscriminatingclearcellcarcinomaandendometrioidcarcinomaoftheovary
AT kawaguchiryuji magneticresonanceimagingfindingsfordiscriminatingclearcellcarcinomaandendometrioidcarcinomaoftheovary
AT yamadayuki magneticresonanceimagingfindingsfordiscriminatingclearcellcarcinomaandendometrioidcarcinomaoftheovary
AT iwaikana magneticresonanceimagingfindingsfordiscriminatingclearcellcarcinomaandendometrioidcarcinomaoftheovary
AT yoshimotochiharu magneticresonanceimagingfindingsfordiscriminatingclearcellcarcinomaandendometrioidcarcinomaoftheovary
AT kobayashihiroshi magneticresonanceimagingfindingsfordiscriminatingclearcellcarcinomaandendometrioidcarcinomaoftheovary